<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 149 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page148.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=149">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 149 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 149</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=149"><img src="../thumb/149.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>118 / 2020-04                                                        Cardio-Vascular Agents - 7.3.9
   (S3) TABS. 36/7.1.3/0382, 0034, 0035, 40/7.1.3/0542  (S3) TABS. 41/7.1.3/0291, 0292, 0770, 0771  hyperkalaem., hypersens.reacts., incr.liv.funct. tests, jaund., hepatit.,
   705488-001: 40 mg, 28, R230,44  711253-001: 5(160) mg, 28, R264.96  vertigo, asthen., myalg.
   700000-001: 80 mg, 28, R306,80  711254-001: 10(160) mg, 28, R301,63  Special precautions: No re-challenge aft. angioed. react., vol./Na
   700710-001: 160 mg, 28, R306,80  719125-001: 5(320) mg, 28, R373,15  deplet.pts., ren.funct. chang.in suscept.indiv., treatm.to be stop.&
   710051-001: 320 mg, 28, R373,14  719126-001: 10(320) mg, 28, R373,15  chang. if pregn.occurs, poss.foet./neonat.morbid./ mortalit., adeq.
   Dosage: Hypertens: Recomm.dos: 80 mg or 160 mg once dly.   Dosage: Pts.using same compon.dos.from separ. tabs.may be switch.  contracept.in women of child-bear. potent., excret.in milk of lactat.
   Substant.eff.pres.within 2 wks.& max. eff.aft. 4 wks. May be incr.  Recomm.dos: 1 tab./day.  rats, monit.pts.at hyperkalaem. risk, lact.intol., monit.K/creatin.lev. in
   to 320 mg dly.or add diuret.in pts.not adeq.control. May be admin.   Contraindications: Angio-oed.with prev.ACE-inhibit./ angiotens.  impair.ren.funct., renin-angiotensin-aldosterone syst.activ.
                                                                       -
                                                                             -
   with other anti-hypertens.   recept.block., sev. ren.impairm., heredit./idiopath.angioed., aort.  Drug interactions: Kspar.diuret., Ksupplem.or salt substit.contain.K
   Post MI: Ther may be init.as early as 12 hrs.aft. MI. Init: 20 mg   stenos., hypertroph. obstruct.cardiomopathy, bilat.& unilat. ren. ar-  may lead to incr.ser.K.
   2xdly., titrat.to 40 mg, 80 mg, & 160 mg 2xdly.over next few wks.   tery stenos., concom.K-spar.diuret.(e.g. spironolactone, triamterene,   JUBITAN, (Forrester) LeBasi [P/S]
   Target.dos: 160 mg 2xdly.to be achiev.by 3 mnths.bas.on pt tol. May   amiloride)/Li.therap., porphyr., safety in pregn.not est., lactat., safety
   be used with other post MI ther.eg. thrombolyt./ acetylsalicyl.acid/  & effic. in childr.& adolesc.und.18 yrs.not est.  Irbesartan
                                                              Indications: Essent.hypertens.alone/combin.with other antihyper-
   beta-block & statins.        Side effects: Nasopharyngit., flu., hypersens. incl. ser. sickn.& vascu-  tens., diab.nephropathy with elev. ser. creatin.& proteinur.in type
   Heart fail: Init.40 mg 2xdly. Titr.up to 80 mg & 160 mg 2xdly.to high.  lit., vis.disturbs., anx., CNS effs., vertigo, tinnit., tachycard., palpitat.,   2 diab.& hypertens.
   dos.tolerat. Consid.reduc. concom. diuret. Max.dly.dos.in clinic.trails:   syncope, orthostat. hypotens., hypotens., cough, pharyngolaryngeal   (S3) TABS, 46/7.1.3/0124, 0125
   320 mg in div.dos.           pain, GI disturbs., rash, erythema, hyperhidros., exanthema, prurit.,   723194-001: 150 mg, 28, R72,80
   Contraindications: Safety in pregn.& lactat.not est., mod.to sev.  joint swell., back pain, arthralg., myalg., musc.spasm. heavy sensat.,   723203-001: 300 mg, 28, R72,80
   ren.impairm., safety & effic.in childr. & adolesc.und.18 yrs.not est.  pollakiur., polyur., erect.dysfunct., oed., pitt.oed., fac.oed., periph.oed.,   Dosage: Adults: Usual recomm.init.& maint.dos: 150 mg once
   Side effects: Common: Vir.infect., neutropen., postur.dizzin., orthos-  fatig., flush., asthen., hot flush., leucopen., thrombocytopen., hyper-  dly. If insuffic.control.dos may be incr. to 300 mg or other antihy-
   tat.hypotens. Uncommon: URTI, pharyngit., sinusit., hyperkalaem.,   glycaem., pancreatit., hepatit., angioed., dyspn., rhinit., alopec., incr.  pertens.may be add.
   insomn., decr. libido, syncope, vertigo, card. fail., hypotens., cough,   sweat., incr.urin.freq., mood changes, depress., asthen., gynaeco-  Hypertens.& type 2 diabet.ren.dis: Maint.dos. of 300 mg once dly.
   diarrh., abdom.-/back pain, fatig., asthen., oed. Rare: Dizzin. Very   mast., impot., incr.pulm.oed.incid.in NYHA III & IV HF of non-ischaem.  Intravasc.vol.deplet: Init.ther.with low.dos.
   rare: Rhinit., thrombocytopen., hypersens.reacts.incl.ser.sickn., vas-  aetiology, vir.infect., URTI, neutropen., hyperkalaem., decr.libido, ren.   Contraindications: Pregn., lactat., safety & effic. in childr.young.
   culit., headache, naus., angioneurot.oed, rash, prurit.,arthralg., myalg,   impairm., ac.ren.fail., ren.insuff., decr.Hb & haematocrit., incr. ser.cre-  than 6 yrs.not est., angioed. hist. relat. to prev.ACE inhib./angiotens.
   ren impairm.incl.ren.fail.   atinine/K /total bilirub./ bld. urea, elev. liv.funct.val.  recept.block. ther., heredit./idiopath.angioed., hypertroph. obstruct.
                                    +
   Warnings and special precautions: Teratogenic. in experim.  Warnings and special precautions: Teratogenic. in experim.   cardiomyopath., mod.to sev.ren.funct. impairm., bil./sngl.ren.art.
   anim., discont.ther.if pregn. detect., Na & vol.deplet.theref.correct.  anim., ren.& hepat. impairm., bil.obstruct.disords., Na & vol.deplet.   stenos., aort.stenos., concom. K -spar.diurets., porphyr., concom.Li,
                                                                           +
   bef. init. ther., concom.K-spar.diuret., K supplem.or Ksalt substit.,   theref. correct.bef.init.ther., concom. K-spar. diuret./K supplem./K -  concom. aliskiren in diab.pts./imp.ren.funct.
                                                 -
                                                       -
                   -
             -
                         -
                                           +
   ren.funct.assessm in post MI & HF pts., consid.dos.reduct.in case   salt substit.or meds.incr. K lev.  Side effects: Dizzin., hypersens.reacts., hyperkalaem., headache, tin-
   of symptomat. hypotens./ ren dysfunct., monit.bld.urea & ser. cre-  Drug interactions: Incr.K+ lev with K-spar. diuret./ K supplem.or K -  nit., vertigo, card. disords., hypotens., oed., flush., cough, GI disturbs.,
                                                -
                                                      -
   atinine in pts.with bilat. & unilat.ren.artery stenos., bil.obstruct.dis-  salt substit./other meds. that may incr.K+ lev.(heparin, etc.)  incr.LFT, hepatit., musculoskelet./chest pain, myalg., arthralg., musc.
   ords., init.ther.in HF/post MI., incr.mortal.with concom.ACE.inhibit.&   See also MDR page 553.  cramps, fatig., sex./ dysfunct.
   beta-block.in HF pts.                                      Warnings and special precautions: No re-challenge aft.angioed.
                   -
                         -
   Interactions: Incr.ser.K+ lev with K-spar.diuret./ K supplem.or   FORTZAAR, MSD  react., treatm.to be stopp. & chang. if pregn.contempl./confirm., adeq.
   Ksalt substit.               Losartan potassium 100 mg, hydrochlorothiazide 25 mg.  contracept. ensur.in women of childbear.potent., vol. &/salt deplet.
   -
                                Indications: Hypertens.in pts.est.on identic.dos. of these indiv.
   DYNAVAL, Pharma Dynamics [P/S]  ingreds.                   pts., dehydrat.risk, rec.kidn. transpl., not for lact.intol.pts., hypotens.,
                                                                                        +
   Valsartan                    (S3) TABS. 34/7.1.3/0281      renin-angiotens.-aldoster.syst.activ., imp.ren.funct., monit. ser.K  lev.,
                                                                                         +
   Indications: Mild to mod.hypertens., post MI in stable pts.with   887096-005: 30, R154,84  not recomm.in prim.aldosteron., type 2 diab., ren.dis., monit.ser.K  in
   evid.of L.ventric.fail.and/or L ventric. systol.dysfunct., heart fail.  Dosage: 1 tab.dly. Max.therapeut.eff.attain.within 3 wks. of ini-  risk pts., not to be used in pts.with diab.nephropathy, concom. Li not
   (NYHA class II-IV)           tiat.of ther.                 recomm., concom.NSAIDs esp.elderly.
   (S3) TABS. A43/7.1.3/0949, 0950  Contraindications: Angioed.hist.relat.to prev. ACE inhibit./angio-  Interactions: Toxic.with concom.Li, poss.add. hypotens. eff.with
   723724-001 80 mg, 30, R125,62  tens.recept.ther., heredit./ idiopath. angioed., hypertroph.obstruct.   diurets., meds.inhibit./meds. metabol. by P450 2C9 isoenzym., incr.
                                                                          +
                                                                                        +
                                                                +
                                                              ser.K with K spar. diurets., K supplem./salt substit.contain.K , Li-
                                                                   +
   723725-001 160 mg, 30, R125,62  cardiomyopathy, sev.ren.funct.impairm., bilat.ren. artery stenos., ren.
                                                          +
   Dosage: Admin.without crush./chew.  artery stenos.in pts.with with sngl. kidn., aort.stenos., concom.K  spar.  toxic. with incr.ser.Li conc., incr.antihypertens. eff./ ren.funct.worsen.
                                                              risk with NSAIDs, incr.S/E freq. with concom.ACE inhib./angiotens.ll
   Hypertens: Recomm.dos: 80 mg or 160 mg once dly. Substant.   diuret, porphyr., Addisons dis., anur.& sev.ren.impairm., sulphonam.-
   eff.pres.within 2 wks.& max.eff.aft. 4 wks. May be incr.to 320 mg   deriv.meds.hypersens., concom.Li ther., pregn.& lactat., hepat.im-  recept. block.or aliskiren.
   dly.or add diuret.in pts.not adeq.control. May be admin.with other   pairm., safety in childr. not est.  LOSAAR PLUS, Accord
   anti-hypertens.agents.       Side effects: Dizzin./asthen., fatig., orthostat. hypotens., headache,   Losartan potassium 50(100) mg, hydrochlorothiazide 12,5(25) mg.
   Post MI: Init.as early as 12 hrs.post MI in clinic. stable pts. Init.dos:   insomn., rash, abdom.pain, pancreatit., chest pain, oed., palpitat.,   Indications: Hypertens.in pts.est.on identic.dos. of these indiv.
   20 mg 2xdly.then titr.to 40 mg, 80 mg & 160 mg 2xdly over next few   tachycard., GI disturbs., skin disords., photosens., vasc. disords., hy-  agents.
   wks. Targ. dos: 160 mg 2xdly to be achiev.by 3 mnths.bas.on toler.  potens., resp.disords.incl.resp.distress, fev., weakn., back pain, musc.  (S3) TABS. 42/7.1.3/0325, 0326
   dur.titrat. May be used with other post MI ther. e.g.thrombolyt./ace-  cramps, cough, nas. congest., pharyngit., sinus disords., URTI., vertigo,   715856-001: 50(12,5) mg, 30, R82,50
   tylsalicyl.acid/beta-blocks./ statins.  paraesthes., xanthopsia, bld.disords., arthralg., hypersens. reacts.incl.  715857-001: 100(25) mg, 30, R91,50
   Heart fail: Recomm.dos: 40 mg 2x dly. Up-titrat. to 80 mg & 160 mg   angioed., hyperglycaem., glycosuria, hyperuricaem, anorex., electrol.  Dosage: Usual init./maint.dos: one 50/12,5 mg tab.dly. May be
   2xdly to high.dos.tol. Dos. reduct.of concom.diurets.may be cons. Max   imbal., ren. dysfunct./fail., interstit.nephrit., trans.blurr. vis., poss.  chang.to one 100/25 mg tab.once dly.or two 50/12,5 tabs.once dly.
   320 mg dly. in div.dos.      precipitat.of hyperuricaem/gout, activat./ exacerbat.of SLE, incr.ALT,   which is the max. dos. Max.therap.eff.attain.within 3 wks.aft. ther.
   Contraindications: Angioed.hist.relat.to prev. ACE-inhibit./ARB   jaund., hepatit., interstit. nephrit., CNS & psych.disords.  init. May be admin.with other anti-hypertens.
   ther., heredit./idiopath.angioed., mod.to sev.ren. funct. impairm.(crea-  Warnings and special precautions: Adeq. contracept. for women   Contraindications: Anur., sulphonam. hypersens., prev.angioed.
   tin. clear.less than 30 ml/min.), hypertroph.obstruct. cardiomyopathy,   of childbear.age & discont. immed.if pregn./suspect., sev.ren./hepat.  relat.to ACE/ARB ther., heredit./ idiopath.angioed., hypertroph.ob-
   bil.ren.art./aort.stenos., ren.art. stenos.with sngl.kidn., concom.K   +  impairm., correct intravasc.vol.deplet.bef.init./start.low.dos., monit.   struct. cardiomyopathy, mod.to sev.ren.funct.impairm., bilat. ren.
              +
   spar.diuret./K supplem./K cont. substit., porphyr., sev.liv. impairm./   electrol.bal.in pts.on diuret., poss.dos. adjustm. of antidiabet.agents,   art.stenos., ren.artery stenos.with sngl. kidn., aort.stenos., con-
        +
                                                                 +
   cirrhos./biliary obstruct./cholestasis, Li ther., pregn., safety in lactat.  decr.Ca excret.lead. to poss. elev.ser.Ca levels, poss.incr.in choles-  com. K spar.diuret./Li ther., porphyr., Addison’s dis., pregn. & lactat.
   not est., concom. aliskiren-contain.prods., safety & effic.in childr.&   terol & trigylceride lev., lact.intol., admin.1 hr.bef.anion. exchang.  Side effects: Bld.disords.incl.Henoch-Schonlein purp./ ecchymos.,
   adolesc.bel.18 yrs.not est.  resins, monit.ser.Li lev.     anaphylact./sens.reacts., anorex., headache, dizzin., CNS effs.,
                                                    +
                                              +
                                          +
   Side effects: Freq: Vir.infects., neutropen., dizzin. /postur. dizzin.,   Interactions: Incr.ser.K with K -spar.diuret./K  supplem./ subst.,   paraesthes., periph. neuropathy, trem, blurr.vis., xanthops., sting.
   hypotens./orthostat.hypotens., ren. impairm. Less freq: URTI, phar-  alcoh./barbit.& narcot.potent. orthostat. hypotens., potent.of other   eyes, conjunctivit., decr.vis.acuity, vertigo, tinnit., card.disords.incl.
   yngit./sinusit, rhinit., thrombocytopen., hypersens.incl.ser.sickn.,   antihypertens., absorpt.of hydrochlorothiazide imp. in pres.of anionic   sternalg./ang.pect./grade II-AV block, cerebrovasc.event, MI, pal-
   angioed., hyperkalaem., hypernatraem., insomn., decr. libido, syn-  exchange resins, intensif. electrol. deplet.with corticoster.& ACTH,   pitat., dysrhythm., vasculit., GI disturbs., hepatit., liv. funct. abnorm.,
   cope, headache, vertigo, card.fail., vasculit., cough, diarrh., abdom.  decr. respons. to press.amines, incr.responsiven.to nondepolaris. skel-  alopec., skin reacts.incl.tox. epiderm. necrolys., flush., photosens.,
   pain, naus., prurit., rash, back pain, arthralg./myalg., ac.ren.fail., ren.   et.musc.relax., reduc.Li clear., NSAID’s may reduc.diuret./natriuret.&   sweat, musc. cramps/weakn., myalg., leg/back/arm/knee/ should./
   insuffic., fatig., asthen., oed., elev.liv.funct.val.in hypertens.pts. Un-  antihypertens. eff., NSAID’s furth.reduc.ren.funct. in ren.impairm.  chest/musculoskelet./dent. pain, stiffn., arthralg., arthrit., coxalg.,
   known freq: Decr. haematocrit./ haemoglob., incr.ser.creatin./bilirub.  fibromyalg., ren./urin./ psych./sinus disords., UTI, decr.libido, im-
   Warnings and special precautions: No re-challenge aft.angioed.  IRBEWIN, Zentiva [P/S]  pot., fac. oed., fev., hyperglycaem., hyperuricaem., hypokalaem., hy-
   react., discont.ther.if pregn. susp/ plann., adeq.contracept.in women   Irbesartan  ponatraem., orthostat.hypotens., sialoadenit., intrahepat.cholestas.,
   of child-bear.age, hypotension, Na & vol.deplet.theref. correct. bef.  Indications: Essent.hypertens.alone/combin.with other antihy-  pancreatit., photosens., glycosur., interstit.nephrit., ren. dysfunct./fail.,
   init.ther./admin.low.dos., poss.tox.Li-conc.with concom. Li, ren.funct.  pertens., diabet. nephropathy with elev.ser.creatinine & proteinur.  URTI., pharyng.discomf., pharyngit., laryngit., dyspn., epistax., resp.
   assessm.dur.eval. of post-MI/HF pts., monit.ser.K lev.esp.in elderly/   in type II diab.& hypertens.  congest./distress, pneumonit./pulm.oed.
                       +
   ren.impairm., avoid concom. K spar.diurets., monit. bld. urea/ser. crea-  (S3) TABS, A40/7.1.3/0288, 0289  Warnings and special precautions: No re-challenge aft.angioed.
               +
   tin.in pts.with ren.art.stenos., hepat. impairm. hist., post-MI/HF, incr.  712385-001: 150 mg, 28, R115,93  react., treatm.to be stopp.& chang. if pregn.occurs/plann., adeq.con-
   mortalit.in HF pts.receiv. Dynaval/ACE inhibit./beta-block. concom., HF   712385-002: 150 mg, 30, R124,31  tracept.in women of childbear.potent., teratogen.in experim. animals,
   pts where ren.funct.depend.on renin-angiotens.-aldost.syst., incr.ren.  712384-001: 300 mg, 28, R132,96  cross.placenta, not recomm.in hepat. impairm./ sev.ren.impairm., dos.
   impairm.risk with concom. NSAIDs partic.in case of inadeq.hydrat,   712384-002: 300 mg, 30, R142,53  adjustm.of antidiabet. agents poss., admin.1 hr bef.anion. exchange res-
   dual block.of RAAS with ARB’s/ACE inhibit./ aliskiren assoc.with high.  Dosage: Init.& maint. dos: 150 mg once dly. If control insuffic.dos.  ins intake, poss.Li-toxic., correct intravasc. vol.deplet.bef.init./low.dos.,
   freq.hypotens./ hyperkalaem. & decr.ren.funct., consid.dos.reduct. in   may be incr.to 300 mg or other antihypertens.may be add.  per. electrol. monit., mark.hypercalcaem., decr.Ca excret. lead.to poss.
   symptomat. hypotens./ren.dysfunct.  Hypertens.with type 2 diabet.ren.dis: Pref.maint.dos: 300 mg   elev.serum Ca lev., poss.incr. cholester. & triglycer. lev., gout &/ hyperu-
   Interactions: Antihypertens.eff.potent.by meds./ agents low.BP/  once dly.  ricaem. poss. precipit., activat./exacerbat.of SLE, not for lact. intol.indiv.
                          +
                    +
   NSAID, poss.incr.hyperklaem. eff. with K  spar.diurets./K  supplem./  Contraindications: Angioed.hist.relat.to prev. ARB ther., heredit./  Interactions: Eff.potent.if admin.with other antihypertens., alcoh./
   other meds. caus. hyperkalaem.  idiopath.angioed., hypertroph. obstruct. cardiomyopathy, mod.to sev.  barbit./narcot.potent. orthostat. hypotens., absorpt.of hydrochlorothi-
                                ren.funct. impairm., bi-/unilat.ren.art.stenos.in pres.of sngl. kidn., aort.  az. imp. in pres.of anion.exchange resins, intensif. electrol. deplet.with
   EXFORGE, Novartis [P/S] &    stenos., concom.K-spar.diurets., porphyr., concom.thiaz.diurets.in fix.  corticoster.& ACTH, decr. respons. to press.amin., incr.responsiven.to
   Amlodipine 5(10) mg, valsartan 160(160) mg.  dos.combinat. in Addison’s dis., anur., sulphonam.hypersens., Li-ther.,   nondepolaris. skelet.musc.relax., reduc.clear.of Li, NSAID’s may at-
   Amlodipine 5(10) mg, valsartan 320(320) mg.  safety in pregn.& lactat.not est., safety & effect. in paed.pts.not est.  tenuate diuret./natriuret.& antihypertens. eff., addit.hyperkalaem.
   Indications: Mild to mod.essent.hypertens.in pts. stabilis.on same   Side effects: Poss.Li toxic., hypotens., dizzin, tachycard., cough, N&V,   eff.with K  supplem./K -spar.& thiazide diuret.& other meds. caus.
                                                                  +
                                                                        +
   dos.of indiv.compon.         diarrh., dyspeps., sex. dysfunct., fatig., chest pain, oed., headache,   hyperkalaem., rifampic.& fluconaz.reduc.act. metabol.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page148.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page144.html">144</a>&nbsp;&nbsp;&nbsp;<a href="page145.html">145</a>&nbsp;&nbsp;&nbsp;<a href="page146.html">146</a>&nbsp;&nbsp;&nbsp;<a href="page147.html">147</a>&nbsp;&nbsp;&nbsp;<a href="page148.html">148</a>&nbsp;&nbsp;&nbsp;<a href="page149.html">149</a>&nbsp;&nbsp;&nbsp;<a href="page150.html">150</a>&nbsp;&nbsp;&nbsp;<a href="page151.html">151</a>&nbsp;&nbsp;&nbsp;<a href="page152.html">152</a>&nbsp;&nbsp;&nbsp;<a href="page153.html">153</a>&nbsp;&nbsp;&nbsp;<a href="page154.html">154</a>
             </td>
             <td width="35%"><a href="page150.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page150.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
